Cargando…
Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
Colorectal cancer (CRC) is one of the most frequent cancers and is a leading cause of cancer death worldwide. Treatments used for CRC may include some combination of surgery, radiation therapy, chemotherapy, and targeted therapy. The current standard drugs used in chemotherapy are 5-fluorouracil and...
Autores principales: | Rodrigues, Daniela, Longatto-Filho, Adhemar, Martins, Sandra F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983659/ https://www.ncbi.nlm.nih.gov/pubmed/27563673 http://dx.doi.org/10.1155/2016/6896024 |
Ejemplares similares
-
Exploiting monocarboxylate transporters as new molecular targets for colorectal carcinoma therapy
por: Amorim, Ricardo, et al.
Publicado: (2013) -
Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?
por: Macedo, Filipa, et al.
Publicado: (2017) -
Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020) -
Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018) -
Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival
por: Martins, Sandra F., et al.
Publicado: (2015)